Therapeutics

Research studying the use of new and existing drugs for combating the virus

Published and Preprint Papers

Drugs

Title

Altmetric

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Effect of Early Treatment with Ivermectin among Patients with Covid-19.

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19.

convalescent plasma, methylprednisolone

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

azithromycin, hydroxychloroquine

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.

hydroxychloroquine

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.